SPOP and prostate cancer: The majority (>97%) of SPOP mutations detected in prostate cancer patient samples is localized in the substrate-binding MATH domain28,30, suggesting that tumorigenesis linked to SPOP mutations originates from deregulation of SPOP substrate ubiquitination.